Abstract
1,5-Benzodiazepines are one of the important class of tranquilizers. The fusion of heterocyclic systems like coumarins and indolines with the benzodiazepine seems quite encouraging for the synthesis of derivatives with enhanced anti-anxiety property. The benzodiazepine derivatives containing fluorine were synthesized and studied for their anti-anxiety activity on mice using plus maze apparatus with sodium pentabarbitone as the standard. Compound with mono substituted fluorine showed comparable anti-anxiety activity with the standard. The docking studies with Translocator protein (TSPO) (PDB: 4UC2) were done and further supported by molecular dynamics simulations. The in vivo test results are in well agreement with docking and molecular dynamics simulation studies.
Similar content being viewed by others
REFERENCES
Narayana, B., Vijaya Raj, K.K., Ashalatha, B.V., and Sucheta, K.N., Eur. J. Med. Chem., 2006, vol. 41, no. 3, pp. 417–422. https://doi.org/10.1016/j.ejmech.2005.12.003
Shader, R.I. and Greenblatt, D.J., N. Engl. J. Med., 1993, vol. 328, pp. 1398–1405. https://doi.org/10.1056/NEJM199305133281907
McKernan, R.M., Rosahl, T.W., Reynolds, D.S., Sur, C., Wafford, K.A., and Atack J.R., Nat. Neurosci., 2000, vol. 3, pp. 587–592. https://doi.org/10.1038/75761
Chweh, A.Y., Lin Y.B., and Swinyard, E.A., Life Sci., 1984, vol. 34, pp. 1763–1768. https://doi.org/10.1016/0024-3205(84)90576-9
Wright, W.B., Greenblatt, E.N., Day, I.P., Quinones N.Q., and Hardy, R.A., J. Med. Chem., 1980, vol. 23, pp. 462–465. https://doi.org/10.1021/jm00178a020
Hamilton. J.T., Can. J. Physiol. Pharmacol., 1967, vol. 45, pp. 191–198. https://doi.org/10.1139/y67-022
Kukla, M.J. and Berslin, H.J., J. Med. Chem., 1991, vol. 34, pp. 746–751. https://doi.org/10.1021/jm00106a040
Cortez-Maya, S., Hernández-Ortega, S., Ramírez-Apan, T., Lijanova, I.V., and Martínez-García, M., Bioorg. Med. Chem., 2012, vol. 20, pp. 415–421. https://doi.org/10.1016/j.bmc.2011.10.070
Goldberg, R., Drugs Across the Spectrum, Cengage Learning, 2009, p.195.
Canning, C., Sun, S., Ji, X., Gupta, S., and Zhou. K., J. Ethnopharm., 2013, vol. 147, pp. 259–262. https://doi.org/10.1016/j.jep.2013.02.026
Kokron, O., Maca, S., Gasser, G., and Schmidt, P.R., Oncology, 1991, vol. 48, pp. 91–102. https://doi.org/10.1159/000226905
Patagar Dayanand, Kusanur Raviraj, Sitwala Nikum, D., Ghate Manjunath, D., Saravanakumar Shanmugasundar, Nembenna Sharanappa, and Gediya Piyush, A., J. Heterocycl. Chem., 2019, vol.56, pp. 2761–2771. https://doi.org/10.1002/jhet.3644
Kaushik, N.K., Kaushik, N., Attri, P., Naresh Kumar, Hyeok Kim Chung, Verma Akhilesh Kumar, and Eun Ha Choi., Molecules, 2013, vol. 18, pp. 6620–6662. https://doi.org/10.3390/molecules18066620
Filler. R., Kobayashi. Y., and Yagupolskii. L.M., Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications (Studies in Org. Chem.), Amsterdam: Elsevier, 1993, vol. 48.
Kirsch, P., Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications, 2nd ed., Wiley-VCH, 2013.
Ojima, I., Fluorine in Medicinal Chemistry and Chemical Biology, New York: Wiley, 2009.
Uneyama, K., Organofluorine Chemistry, Oxford, UK: Blackwell, 2006, p. 339.
Dalvit, C. and Vulpetti, A., Chem. Med. Chem., 2012, vol. 7, pp. 262–272. https://doi.org/10.1002/cmdc.201100483
Schneider H.-J., Chem. Sci., 2012, vol. 3, pp.1381–1394. https://doi.org/10.1039/c2sc00764a
Howard, J.A.K., Hoy, V.J., O’Hagan, D., and Smith, G.T., Tetrahedron, 1996, vol. 38, pp.12613–12622.
Dunitz, J.D. and Taylor, R., Chem. Eur. J., 1997, vol. 3, pp. 89–98. https://doi.org/10.1002/chem.19970030115
Meanwell, N.A., J. Med. Chem., 2011, vol. 54, pp. 2529–2591. https://doi.org/10.1021/jm1013693
Taylor, J.M.W., Allen, A.-M., and Graham A., Clin. Sci., 2014, vol. 127, pp. 603–613. https://doi.org/10.1042/CS20140047
Costa, B., Da Pozzo, E., and Martini, C., Curr. Top. Med. Chem., 2012, vol. 12, pp. 270–285. https://doi.org/10.2174/156802612799078720
Kusanur, R.A., Ghate, M., and Kulkarni, M.V., J. Chem. Sci., 2004, vol. 116, pp. 265–270. https://doi.org/10.1007/BF02708277
Knoevenagel, E., Berichte., 1898, vol. 31, pp. 730–737.
Bagchi, P.P., Ittyeah, P.I., Agra Univ. J. Res., 1955, vol. 14, p. 5.
Crawley, J.N., Godwin, F.K., Pharmacol. Biochem. Behav., 1980, vol. 13, pp. 167–170. https://doi.org/10.1016/0091-3057(80)90067-2
Kilfoil, T., Michel, A., and Montgomony, D., Psyco. Pharmacol., 1988, vol. 28. pp. 901–905.
Schrödinger Release, 2019-3: Desmond Molecular Dynamics System.
D.E. Shaw Research, New York, NY, 2019.
Maestro-Desmond Interoperability Tools, Schrödinger, New York, NY, 2019.
ACKNOWLADGMENTS
he authors are thankful to Rastreeya Sikshana Samithi Trust for constant support and encouragement.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
The article does not involve any human studies. However, for animal studies all applicable international, national and/or institutional guidelines for the care and use of animals were followed.
Conflict of Interests
The authors declare that they have no conflicts of interest.
Additional information
Abbreviations: TSPO, translocator protein; PDB, protein data base.
Corresponding author: phone: +91 9448823443.
Rights and permissions
About this article
Cite this article
Patagar, D., Uttarkar, A., Patra, S.M. et al. Spiro Benzodiazepine Substituted Fluorocoumarins as Potent Anti-Anxiety Agents. Russ J Bioorg Chem 47, 390–398 (2021). https://doi.org/10.1134/S1068162021020199
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162021020199